Plus Therapeutics (PSTV) Enterprise Value (2010 - 2026)
Plus Therapeutics (PSTV) reported Enterprise Value of -$15.1 million for Q1 2026, down 53.18% year-over-year from -$32.3 million in Q1 2025, and down 75.5% quarter-over-quarter from -$8.6 million in Q4 2025.
Plus Therapeutics (PSTV) Enterprise Value (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 17 years of Enterprise Value data on file, last reported at -$15.1 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$15.1 million, down 53.18% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.1 million (down 53.18% YoY), and the FY2025 annual result was -$8.6 million, down 138.82% from the prior year.
- Enterprise Value declined to -$15.1 million in Q1 2026 per PSTV's latest filing, from -$8.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$397000.0 in Q1 2024 and troughed at -$21.2 million in Q1 2022.
- A 5-year average of -$11.5 million and a median of -$10.9 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 96.88% in 2024, then tumbled 2385.39% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$18.1 million in 2022, then soared by 52.79% to -$8.6 million in 2023, then soared by 57.84% to -$3.6 million in 2024, then slumped by 138.82% to -$8.6 million in 2025, then sank by 75.5% to -$15.1 million in 2026.
- Business Quant data shows PSTV's Enterprise Value at -$15.1 million in Q1 2026, -$8.6 million in Q4 2025, and -$16.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -584.73 Mn |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | -15.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.11 Mn |
| Dec 31, 2025 | -8.61 Mn |
| Sep 30, 2025 | -16.60 Mn |
| Jun 30, 2025 | -6.88 Mn |
| Mar 31, 2025 | -9.87 Mn |
| Dec 31, 2024 | -3.61 Mn |
| Sep 30, 2024 | -4.79 Mn |
| Jun 30, 2024 | -8.44 Mn |
| Mar 31, 2024 | -397,000.00 |
| Dec 31, 2023 | -8.55 Mn |
| Sep 30, 2023 | -11.01 Mn |
| Jun 30, 2023 | -10.90 Mn |
| Mar 31, 2023 | -12.72 Mn |
| Dec 31, 2022 | -18.12 Mn |
| Sep 30, 2022 | -20.27 Mn |
| Jun 30, 2022 | -18.09 Mn |
| Mar 31, 2022 | -21.24 Mn |
| Dec 31, 2021 | -18.40 Mn |
| Sep 30, 2021 | -21.28 Mn |
| Jun 30, 2021 | -17.16 Mn |